These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20525780)

  • 1. Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention.
    Ebbert JO; Edmonds A; Luo X; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2010 Aug; 12(8):823-7. PubMed ID: 20525780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
    Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
    Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of nicotine lozenge for smokeless tobacco use.
    Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
    Nicotine Tob Res; 2009 Dec; 11(12):1415-23. PubMed ID: 19880578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine lozenges for the treatment of smokeless tobacco use.
    Ebbert JO; Dale LC; Severson H; Croghan IT; Rasmussen DF; Schroeder DR; Vander Weg MW; Hurt RD
    Nicotine Tob Res; 2007 Feb; 9(2):233-40. PubMed ID: 17365754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.
    Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
    Addict Behav; 2013 May; 38(5):2140-5. PubMed ID: 23454876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing an immediate cessation versus reduction approach to smokeless tobacco cessation.
    Schiller KR; Luo X; Anderson AJ; Jensen JA; Allen SS; Hatsukami DK
    Nicotine Tob Res; 2012 Aug; 14(8):902-9. PubMed ID: 22218402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to assess smokeless tobacco use reduction with varenicline.
    Ebbert JO; Croghan IT; North F; Schroeder DR
    Nicotine Tob Res; 2010 Oct; 12(10):1037-40. PubMed ID: 20724382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Real-World Evaluation of a Smokeless Tobacco Cessation Text Message Program for Veterans: Outcomes and Comparison to Cigarette Smokers.
    Christofferson DE; Blalock DV; Knoeppel J; Beckham JC; Hamlett-Berry K; Hertzberg JS
    Nicotine Tob Res; 2022 Feb; 24(2):186-195. PubMed ID: 34545940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for smokeless tobacco use cessation.
    Ebbert JO; Elrashidi MY; Stead LF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD004306. PubMed ID: 26501380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit.
    Carpenter MJ; Gray KM
    Nicotine Tob Res; 2010 Feb; 12(2):136-43. PubMed ID: 20053788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of the effect of nicotine pre-treatment on quitting smoking.
    Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
    Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of smokeless tobacco in smoking cessation.
    Tilashalski K; Rodu B; Cole P
    Am J Med; 1998 May; 104(5):456-8. PubMed ID: 9626029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of motivation phase intervention components on quit attempts in smokers unwilling to quit: A factorial experiment.
    Engle JL; Mermelstein R; Baker TB; Smith SS; Schlam TR; Piper ME; Jorenby DE; Collins LM; Cook JW
    Drug Alcohol Depend; 2019 Apr; 197():149-157. PubMed ID: 30825795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of nicotine lozenges and phone counseling for smokeless tobacco cessation.
    Severson HH; Danaher BG; Ebbert JO; van Meter N; Lichtenstein E; Widdop C; Crowley R; Akers L; Seeley JR
    Nicotine Tob Res; 2015 Mar; 17(3):309-15. PubMed ID: 25168034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.
    Ebbert JO; Croghan IT; Schroeder DR; Hurt RD
    Nicotine Tob Res; 2013 Dec; 15(12):2037-44. PubMed ID: 23873976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.
    Ebbert JO; Severson HH; Danaher BG; Benowitz NL; Schroeder DR
    Nicotine Tob Res; 2016 Mar; 18(3):366-70. PubMed ID: 25977408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to reduce harm from continued tobacco use.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005231. PubMed ID: 17636791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for smokeless tobacco use cessation.
    Ebbert J; Montori VM; Erwin PJ; Stead LF
    Cochrane Database Syst Rev; 2011 Feb; (2):CD004306. PubMed ID: 21328266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.